MANGANESE

MANGANESE was reported 276 times

MANGANESE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 URINE PHOSPHATE INCREASED 2 0.1667
1 MANGANESE INCREASED 1 0.0833
2 BLOOD ZINC INCREASED 1 0.0333
3 RED BLOOD CELLS CSF POSITIVE 2 0.0260
4 STEM CELL THERAPY 1 0.0169
5 SOMATOSENSORY EVOKED POTENTIALS ABNORMAL 1 0.0167
6 ALPHA 1 GLOBULIN INCREASED 1 0.0125
7 BLOOD CORTICOTROPHIN ABNORMAL 1 0.0104
8 ALPHA 2 GLOBULIN INCREASED 1 0.0101
9 COPPER DEFICIENCY 1 0.0083
10 NASAL ODOUR 1 0.0060
11 PROCEDURAL FAILURE 1 0.0056
12 BLADDER REPAIR 1 0.0055
13 SCHWANNOMA 1 0.0050
14 VENTRICULAR DYSKINESIA 1 0.0048
15 MALIGNANT MELANOMA STAGE 0 1 0.0048
16 IRREGULAR SLEEP PHASE 1 0.0047
17 VAGINAL MUCOSAL BLISTERING 1 0.0044
18 CONGENITAL HIATUS HERNIA 1 0.0044
19 GRANULOMA ANNULARE 3 0.0041
20 BACTEROIDES INFECTION 1 0.0038
21 PENILE BURNING SENSATION 1 0.0035
22 VITAMIN D INCREASED 2 0.0032
23 INTRACRANIAL HYPOTENSION 2 0.0031
24 BLOOD VISCOSITY DECREASED 1 0.0030
25 HEMIPLEGIC MIGRAINE 1 0.0029
26 COUNTERFEIT DRUG ADMINISTERED 1 0.0029
27 JOINT ABSCESS 1 0.0029
28 TONGUE EXFOLIATION 1 0.0028
29 ESSENTIAL THROMBOCYTHAEMIA 1 0.0027
30 ORGASMIC SENSATION DECREASED 1 0.0026
31 APPENDICOLITH 1 0.0026
32 URINARY CASTS 1 0.0026
33 OROPHARYNGEAL SPASM 1 0.0024
34 BLOOD PHOSPHORUS ABNORMAL 1 0.0021
35 EXPOSURE VIA PARTNER 1 0.0020
36 SUPRAPUBIC PAIN 1 0.0020
37 LEFT VENTRICULAR DILATATION 1 0.0020
38 GASTROINTESTINAL FUNGAL INFECTION 1 0.0019
39 TRI-IODOTHYRONINE DECREASED 1 0.0019
40 INHIBITORY DRUG INTERACTION 3 0.0019
41 EXECUTIVE DYSFUNCTION 1 0.0018
42 BLOOD MAGNESIUM ABNORMAL 1 0.0018
43 ALLERGY TO METALS 1 0.0016
44 MEDICAL DEVICE SITE INFECTION 1 0.0016
45 PARKINSONIAN GAIT 1 0.0016
46 INFUSION SITE URTICARIA 1 0.0015
47 URINE LEUKOCYTE ESTERASE POSITIVE 1 0.0014
48 INTRAOCULAR PRESSURE TEST ABNORMAL 1 0.0014
49 PUBIS FRACTURE 1 0.0014
50 PARASOMNIA 1 0.0014
51 PALMOPLANTAR KERATODERMA 1 0.0014
52 PARATHYROID TUMOUR BENIGN 1 0.0013
53 BRAIN STEM SYNDROME 1 0.0013
54 AORTIC DISORDER 1 0.0013
55 GROWTH OF EYELASHES 1 0.0013
56 TROPONIN I INCREASED 2 0.0012
57 ELECTRIC SHOCK 1 0.0012
58 FUNCTIONAL GASTROINTESTINAL DISORDER 4 0.0012
59 GENITAL BURNING SENSATION 1 0.0012
60 TESTICULAR ATROPHY 1 0.0011
61 SELF-DESTRUCTIVE BEHAVIOUR 1 0.0011
62 KYPHOSIS 2 0.0011
63 HAEMOCHROMATOSIS 1 0.0011
64 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 1 0.0011
65 INJECTION SITE ULCER 1 0.0011
66 HYPOPHYSITIS 2 0.0010
67 HAEMANGIOMA OF LIVER 1 0.0010
68 GENITAL HYPOAESTHESIA 1 0.0010
69 URINARY BLADDER HAEMORRHAGE 2 0.0009
70 VASCULAR CALCIFICATION 1 0.0009
71 HYPERPHOSPHATAEMIA 2 0.0009
72 INSTILLATION SITE REACTION 1 0.0009
73 BENIGN NEOPLASM 1 0.0009
74 DYSLEXIA 1 0.0009
75 GRANULOMATOSIS WITH POLYANGIITIS 1 0.0008
76 STERNAL FRACTURE 1 0.0008
77 INSTILLATION SITE PAIN 2 0.0008
78 SLOW RESPONSE TO STIMULI 1 0.0008
79 HIRSUTISM 1 0.0008
80 LIP EXFOLIATION 1 0.0008
81 BLOOD PHOSPHORUS INCREASED 2 0.0007
82 CHRONIC FATIGUE SYNDROME 1 0.0007
83 CATAPLEXY 1 0.0007
84 LABELLED DRUG-DRUG INTERACTION ISSUE 1 0.0007
85 RED BLOOD CELL COUNT ABNORMAL 1 0.0007
86 ANKLE OPERATION 1 0.0007
87 ANGIOPLASTY 1 0.0007
88 VASCULAR DEVICE INFECTION 3 0.0007
89 ORAL MUCOSAL EXFOLIATION 1 0.0007
90 TOTAL LUNG CAPACITY DECREASED 1 0.0006
91 DISINHIBITION 1 0.0006
92 GASTRIC DILATATION 1 0.0006
93 SUPRAVENTRICULAR EXTRASYSTOLES 2 0.0006
94 PRODUCT COUNTERFEIT 1 0.0006
95 DRUG SCREEN NEGATIVE 1 0.0006
96 HYPERACUSIS 2 0.0005
97 WHITE BLOOD CELLS URINE POSITIVE 1 0.0005
98 FACE INJURY 2 0.0005
99 ADRENAL DISORDER 1 0.0005
100 MOTION SICKNESS 1 0.0005
101 SOCIAL AVOIDANT BEHAVIOUR 3 0.0005
102 HYPERPARATHYROIDISM 1 0.0005
103 PHOTOPSIA 3 0.0005
104 RADIATION PNEUMONITIS 1 0.0005
105 MENINGITIS 3 0.0004
106 TEMPERATURE REGULATION DISORDER 1 0.0004
107 SPINAL COLUMN INJURY 1 0.0004
108 REACTION TO EXCIPIENT 1 0.0004
109 HAEMANGIOMA 1 0.0004
110 WEIGHT ABNORMAL 1 0.0004
111 DIABETES INSIPIDUS 1 0.0004
112 HAEMATOLOGICAL INFECTION 1 0.0004
113 RETINAL TEAR 1 0.0004
114 STEM CELL TRANSPLANT 1 0.0004
115 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 2 0.0004
116 PARKINSON'S DISEASE 1 0.0004
117 HOSTILITY 1 0.0004
118 LIPOMA 1 0.0004
119 POSTMENOPAUSAL HAEMORRHAGE 1 0.0004
120 LUNG OPACITY 1 0.0004
121 BLOOD POTASSIUM ABNORMAL 1 0.0004
122 AREFLEXIA 1 0.0004
123 TEMPOROMANDIBULAR JOINT SYNDROME 1 0.0004
124 ALCOHOL ABUSE 1 0.0004
125 BREAST SWELLING 1 0.0004
126 LARYNGOSPASM 1 0.0004
127 PLEURITIC PAIN 1 0.0004
128 TRICHORRHEXIS 1 0.0004
129 RESPIRATORY SYMPTOM 1 0.0004
130 METABOLIC DISORDER 2 0.0003
131 SKIN WARM 2 0.0003
132 BLOOD PARATHYROID HORMONE INCREASED 1 0.0003
133 NEGATIVE THOUGHTS 1 0.0003
134 METABOLIC ENCEPHALOPATHY 1 0.0003
135 PENILE PAIN 1 0.0003
136 SCOLIOSIS 2 0.0003
137 TESTICULAR PAIN 1 0.0003
138 POLYMYALGIA RHEUMATICA 1 0.0003
139 SUPRAVENTRICULAR TACHYCARDIA 3 0.0003
140 VENTRICULAR HYPOKINESIA 1 0.0003
141 LOOSE TOOTH 1 0.0003
142 TENDON DISORDER 2 0.0003
143 BREAST ENLARGEMENT 1 0.0003
144 SKIN INJURY 1 0.0003
145 OLIGOHYDRAMNIOS 1 0.0003
146 CLOSTRIDIAL INFECTION 1 0.0003
147 JOINT EFFUSION 2 0.0003
148 CERVICAL VERTEBRAL FRACTURE 1 0.0003
149 VENTRICULAR EXTRASYSTOLES 3 0.0003
150 MICTURITION DISORDER 1 0.0003
151 AORTIC STENOSIS 1 0.0003
152 HEAD DISCOMFORT 5 0.0003
153 SCLERODERMA 1 0.0003
154 HYPOPHOSPHATAEMIA 2 0.0003
155 ARTHROPOD BITE 2 0.0003
156 TENDON INJURY 1 0.0003
157 TROPONIN INCREASED 2 0.0003
158 CONJUNCTIVAL HAEMORRHAGE 1 0.0003
159 GINGIVAL DISORDER 1 0.0003
160 PANIC DISORDER 1 0.0003
161 EPIGASTRIC DISCOMFORT 1 0.0003
162 POLYDIPSIA 1 0.0003
163 MYASTHENIA GRAVIS 2 0.0002
164 SPINAL FUSION SURGERY 1 0.0002
165 THYROID FUNCTION TEST ABNORMAL 1 0.0002
166 MUSCLE FATIGUE 1 0.0002
167 HEPATIC PAIN 1 0.0002
168 PURULENT DISCHARGE 1 0.0002
169 BLOOD CALCIUM INCREASED 2 0.0002
170 PARONYCHIA 1 0.0002
171 GOUT 4 0.0002
172 MENINGITIS ASEPTIC 1 0.0002
173 SYNOVIAL CYST 1 0.0002
174 INTERVERTEBRAL DISC DEGENERATION 2 0.0002
175 MASS 3 0.0002
176 MULTIPLE MYELOMA 1 0.0002
177 CARDIAC TAMPONADE 1 0.0002
178 SUBCUTANEOUS ABSCESS 1 0.0002
179 FAECAL INCONTINENCE 1 0.0002
180 PARAESTHESIA ORAL 3 0.0002
181 RASH VESICULAR 1 0.0002
182 INJECTION SITE HAEMATOMA 3 0.0002
183 RENAL CELL CARCINOMA 1 0.0002
184 BREATH SOUNDS ABNORMAL 1 0.0002
185 ABDOMINAL TENDERNESS 1 0.0002
186 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
187 MALABSORPTION 1 0.0002
188 FULL BLOOD COUNT ABNORMAL 2 0.0002
189 COMPRESSION FRACTURE 1 0.0002
190 PRODUCT SIZE ISSUE 1 0.0002
191 HIP SURGERY 1 0.0002
192 DEAFNESS UNILATERAL 1 0.0002
193 PSYCHOMOTOR HYPERACTIVITY 3 0.0002
194 PRODUCT PHYSICAL CONSISTENCY ISSUE 1 0.0002
195 PERONEAL NERVE PALSY 1 0.0002
196 GENERALISED ERYTHEMA 1 0.0002
197 DERMATITIS CONTACT 2 0.0002
198 SKIN ATROPHY 1 0.0002
199 EXERCISE TOLERANCE DECREASED 1 0.0002
200 BLOOD URIC ACID INCREASED 1 0.0002
201 HYPOVOLAEMIA 1 0.0002
202 ENERGY INCREASED 1 0.0002
203 ODYNOPHAGIA 1 0.0002
204 HYPERLIPIDAEMIA 2 0.0002
205 NEURALGIA 4 0.0002
206 MENISCUS INJURY 1 0.0002
207 TENDON RUPTURE 2 0.0002
208 HYPERCALCAEMIA 2 0.0002
209 AGEUSIA 4 0.0002
210 PRE-EXISTING CONDITION IMPROVED 1 0.0002
211 THERAPEUTIC RESPONSE CHANGED 1 0.0002
212 POST PROCEDURAL COMPLICATION 3 0.0002
213 HAEMOGLOBIN ABNORMAL 1 0.0002
214 CARDIAC FLUTTER 1 0.0002
215 POOR QUALITY DRUG ADMINISTERED 1 0.0002
216 HERPES SIMPLEX 1 0.0002
217 CORONAVIRUS INFECTION 1 0.0002
218 QUALITY OF LIFE DECREASED 2 0.0001
219 POSTOPERATIVE WOUND INFECTION 1 0.0001
220 CENTRAL NERVOUS SYSTEM LESION 2 0.0001
221 PROSTATIC SPECIFIC ANTIGEN INCREASED 2 0.0001
222 ENCEPHALITIS 1 0.0001
223 BLOOD TEST ABNORMAL 2 0.0001
224 SEASONAL ALLERGY 2 0.0001
225 JOINT INJURY 3 0.0001
226 GRAFT VERSUS HOST DISEASE 1 0.0001
227 PANIC REACTION 1 0.0001
228 APATHY 2 0.0001
229 MEDICAL DEVICE COMPLICATION 1 0.0001
230 CEREBRAL DISORDER 1 0.0001
231 SUNBURN 1 0.0001
232 TENDON PAIN 1 0.0001
233 LIPASE INCREASED 1 0.0001
234 MATERNAL DRUGS AFFECTING FOETUS 1 0.0001
235 CONGENITAL ANOMALY 1 0.0001
236 DRUG SCREEN POSITIVE 1 0.0001
237 ULCER 2 0.0001
238 CYSTITIS 4 0.0001
239 HYPOTHYROIDISM 4 0.0001
240 SENSORY LOSS 1 0.0001
241 MUSCLE TIGHTNESS 2 0.0001
242 MUSCLE INJURY 1 0.0001
243 VITAMIN D DECREASED 1 0.0001
244 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
245 MUSCLE STRAIN 1 0.0001
246 URINE OUTPUT DECREASED 1 0.0001
247 SPINAL OSTEOARTHRITIS 1 0.0001
248 TUMOUR LYSIS SYNDROME 1 0.0001
249 PURPURA 1 0.0001
250 RESPIRATORY RATE INCREASED 1 0.0001
251 FACIAL PAIN 1 0.0001
252 HAEMARTHROSIS 1 0.0001
253 END STAGE RENAL DISEASE 2 0.0001
254 BRAIN NEOPLASM 1 0.0001
255 RESPIRATORY DISTRESS 3 0.0001
256 IRON DEFICIENCY ANAEMIA 1 0.0001
257 APPENDICITIS 1 0.0001
258 LACERATION 1 0.0001
259 PAIN IN JAW 3 0.0001
260 EYE INFLAMMATION 1 0.0001
261 SLEEP APNOEA SYNDROME 2 0.0001
262 INCREASED APPETITE 2 0.0001
263 HYPERCHOLESTEROLAEMIA 1 0.0001
264 SINUS BRADYCARDIA 1 0.0001
265 AUTOIMMUNE DISORDER 1 0.0001
266 PARKINSONISM 1 0.0001
267 VITAMIN D DEFICIENCY 1 0.0001
268 SKIN FISSURES 2 0.0001
269 THERAPY CHANGE 1 0.0001
270 BODY TEMPERATURE DECREASED 1 0.0001
271 SPINAL FRACTURE 2 0.0001
272 POOR QUALITY DEVICE USED 1 0.0001
273 TASTE DISORDER 2 0.0001
274 TOOTH ABSCESS 1 0.0001
275 EUPHORIC MOOD 1 0.0001
276 TENDERNESS 1 0.0001
277 BONE DENSITY DECREASED 3 0.0001
278 WEIGHT FLUCTUATION 1 0.0001
279 PRODUCT ODOUR ABNORMAL 1 0.0001
280 DRUG ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
281 BODY HEIGHT DECREASED 1 0.0001
282 SKIN LACERATION 1 0.0001
283 ASPIRATION 1 0.0001
284 DENTAL CARIES 1 0.0001
285 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1 0.0001
286 LIVER DISORDER 4 0.0001
287 VENTRICULAR FIBRILLATION 1 0.0001
288 NERVE INJURY 1 0.0001
289 SKIN INFECTION 1 0.0001
290 OCULAR DISCOMFORT 1 0.0001
291 CHROMATURIA 2 0.0001
292 EYE INFECTION 1 0.0001
293 REBOUND EFFECT 1 0.0001
294 MICTURITION URGENCY 1 0.0001
295 LETHARGY 5 0.0001
296 POLYNEUROPATHY 1 0.0001
297 THYROID CANCER 1 0.0001
298 MENTAL IMPAIRMENT 2 0.0001
299 ADRENAL INSUFFICIENCY 1 0.0001
300 CYTOPENIA 1 0.0001
301 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
302 CARDIOMEGALY 1 0.0001
303 SPINAL OPERATION 1 0.0001
304 DRY EYE 4 0.0001
305 INJECTION SITE DISCOLOURATION 1 0.0001
306 SECRETION DISCHARGE 1 0.0001
307 DERMATITIS ALLERGIC 1 0.0001
308 FEELING ABNORMAL 19 0.0001
309 MUSCLE ATROPHY 1 0.0001
310 INTRAOCULAR PRESSURE INCREASED 1 0.0001
311 ERECTILE DYSFUNCTION 2 0.0001
312 ANOREXIA 1 0.0001
313 INFLAMMATION 4 0.0001
314 RASH GENERALISED 2 0.0001
315 INJECTION SITE INDURATION 1 0.0001
316 HAND DEFORMITY 1 0.0001
317 INCORRECT PRODUCT STORAGE 1 0.0001
318 ABNORMAL BEHAVIOUR 3 0.0001
319 EYE HAEMORRHAGE 1 0.0001
320 JOINT RANGE OF MOTION DECREASED 1 0.0001
321 FREQUENT BOWEL MOVEMENTS 2 0.0001
322 PRODUCT TASTE ABNORMAL 1 0.0001
323 IMPAIRED GASTRIC EMPTYING 1 0.0001
324 AKATHISIA 1 0.0001
325 PERIPHERAL COLDNESS 1 0.0001
326 ARTHROPATHY 4 0.0001
327 HUNGER 1 0.0001
328 HAEMOPTYSIS 2 0.0001
329 COORDINATION ABNORMAL 1 0.0001
330 MULTIPLE ORGAN DYSFUNCTION SYNDROME 2 0.0001
331 HYPERSOMNIA 2 0.0001
332 CARDIOGENIC SHOCK 1 0.0001
333 MUSCULOSKELETAL STIFFNESS 6 0.0001
334 BONE PAIN 4 0.0001
335 PSYCHOTIC DISORDER 2 0.0001
336 URINARY INCONTINENCE 2 0.0001
337 CATARACT 4 0.0001
338 PULMONARY MASS 1 0.0001
339 IMMUNODEFICIENCY 1 0.0001
340 ECONOMIC PROBLEM 1 0.0001
341 ILL-DEFINED DISORDER 4 0.0001
342 VERTIGO 4 0.0001
343 DRUG DISPENSING ERROR 1 0.0001
344 THYROID DISORDER 1 0.0001
345 ANKLE FRACTURE 1 0.0001
346 DELUSION 1 0.0001
347 THERAPY PARTIAL RESPONDER 1 0.0001
348 HEAD INJURY 2 0.0001
349 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
350 NEUROPATHY PERIPHERAL 6 0.0001
351 PREMATURE DELIVERY 1 0.0001
352 RASH ERYTHEMATOUS 3 0.0001
353 MOOD SWINGS 2 0.0001
354 DRY MOUTH 5 0.0001
355 BACK DISORDER 1 0.0001
356 LUNG DISORDER 3 0.0001
357 MULTIPLE FRACTURES 1 0.0001
358 MANIA 1 0.0001
359 MUSCLE SPASMS 11 0.0001
360 PALPITATIONS 7 0.0001
361 ANXIETY 17 0.0001
362 HAEMATURIA 2 0.0001
363 MUSCULOSKELETAL DISCOMFORT 1 0.0001
364 NERVOUSNESS 3 0.0001
365 LOCAL SWELLING 1 0.0001
366 RASH MACULAR 2 0.0001
367 NEUROTOXICITY 1 0.0001
368 DEPRESSED MOOD 3 0.0001
369 COLD SWEAT 1 0.0001
370 LYMPHOCYTE COUNT DECREASED 1 0.0001
371 INSOMNIA 15 0.0001
372 THIRST 1 0.0001
373 GASTROINTESTINAL DISORDER 5 0.0001
374 DISTURBANCE IN ATTENTION 3 0.0001
375 SYNOVITIS 1 0.0001
376 GASTROENTERITIS VIRAL 1 0.0001
377 RASH PRURITIC 3 0.0001
378 TOOTHACHE 1 0.0001
379 CRYING 2 0.0001
380 PANIC ATTACK 2 0.0001
381 DYSURIA 2 0.0001
382 INJECTION SITE MASS 2 0.0001
383 WEIGHT DECREASED 15 0.0001
384 BACTERIAL INFECTION 1 0.0001
385 UNEVALUABLE EVENT 4 0.0001
386 HYPOCALCAEMIA 1 0.0001
387 MUSCULAR WEAKNESS 6 0.0001
388 GASTRIC ULCER 1 0.0001
389 PRODUCT SUBSTITUTION ISSUE 3 0.0001
390 DRUG PRESCRIBING ERROR 1 0.0001
391 GLAUCOMA 1 0.0001
392 ORAL HERPES 1 0.0001
393 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
394 DISORIENTATION 2 0.0001
395 HAEMATOCRIT DECREASED 1 0.0001
396 BLOOD PRESSURE ABNORMAL 1 0.0001
397 INJECTION SITE HAEMORRHAGE 4 0.0001
398 IRRITABILITY 3 0.0000
399 PRODUCT PHYSICAL ISSUE 1 0.0000
400 PLEURAL EFFUSION 3 0.0000
401 BONE MARROW FAILURE 1 0.0000
402 DISCOMFORT 3 0.0000
403 RIB FRACTURE 1 0.0000
404 EXPOSURE DURING PREGNANCY 3 0.0000
405 TREMOR 8 0.0000
406 INTENTIONAL DRUG MISUSE 1 0.0000
407 KNEE ARTHROPLASTY 1 0.0000
408 HALLUCINATION, VISUAL 1 0.0000
409 EATING DISORDER 1 0.0000
410 LOSS OF CONSCIOUSNESS 6 0.0000
411 IMPAIRED WORK ABILITY 1 0.0000
412 IRRITABLE BOWEL SYNDROME 1 0.0000
413 LIVER FUNCTION TEST INCREASED 1 0.0000
414 HYPERHIDROSIS 6 0.0000
415 POOR QUALITY SLEEP 1 0.0000
416 FAECES DISCOLOURED 1 0.0000
417 INTENTIONAL PRODUCT MISUSE 4 0.0000
418 PERIPHERAL SWELLING 7 0.0000
419 MELAENA 1 0.0000
420 TACHYCARDIA 4 0.0000
421 TRANSAMINASES INCREASED 1 0.0000
422 ORAL PAIN 1 0.0000
423 SNEEZING 1 0.0000
424 PARAESTHESIA 7 0.0000
425 HEART RATE IRREGULAR 1 0.0000
426 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
427 SUICIDAL IDEATION 4 0.0000
428 TINNITUS 2 0.0000
429 SKIN DISCOLOURATION 2 0.0000
430 MUSCLE TWITCHING 1 0.0000
431 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
432 OROPHARYNGEAL PAIN 4 0.0000
433 RENAL DISORDER 2 0.0000
434 BLOOD CHOLESTEROL INCREASED 2 0.0000
435 COGNITIVE DISORDER 2 0.0000
436 SLEEP DISORDER 3 0.0000
437 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3 0.0000
438 LOCALISED INFECTION 1 0.0000
439 FIBROMYALGIA 1 0.0000
440 FATIGUE 32 0.0000
441 ATRIAL FIBRILLATION 4 0.0000
442 OEDEMA PERIPHERAL 5 0.0000
443 LIVER INJURY 1 0.0000
444 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
445 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
446 CARDIOVASCULAR DISORDER 1 0.0000
447 DIABETES MELLITUS 3 0.0000
448 FLUID RETENTION 2 0.0000
449 COUGH 11 0.0000
450 HEPATITIS 1 0.0000
451 CHEST DISCOMFORT 4 0.0000
452 SINUSITIS 4 0.0000
453 DECREASED APPETITE 9 0.0000
454 UNRESPONSIVE TO STIMULI 1 0.0000
455 SKIN ULCER 1 0.0000
456 PHARMACEUTICAL PRODUCT COMPLAINT 1 0.0000
457 DIPLOPIA 1 0.0000
458 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
459 DIZZINESS 19 0.0000
460 EAR INFECTION 1 0.0000
461 ASTHENIA 14 0.0000
462 DRUG EFFECT DECREASED 2 0.0000
463 PNEUMONITIS 1 0.0000
464 HEADACHE 23 0.0000
465 INFLUENZA LIKE ILLNESS 3 0.0000
466 ANAPHYLACTIC REACTION 2 0.0000
467 FEELING COLD 1 0.0000
468 NECK PAIN 2 0.0000
469 SKIN EXFOLIATION 3 0.0000
470 HYPONATRAEMIA 2 0.0000
471 EYE PAIN 2 0.0000
472 ASTHMA 4 0.0000
473 MYALGIA 6 0.0000
474 DEPRESSION 8 0.0000
475 RED BLOOD CELL COUNT DECREASED 1 0.0000
476 HERPES ZOSTER 2 0.0000
477 BALANCE DISORDER 3 0.0000
478 DYSSTASIA 1 0.0000
479 SURGERY 2 0.0000
480 NASAL CONGESTION 2 0.0000
481 ASCITES 1 0.0000
482 LABORATORY TEST ABNORMAL 1 0.0000
483 RESPIRATORY DISORDER 1 0.0000
484 BLOOD POTASSIUM DECREASED 1 0.0000
485 JOINT SWELLING 4 0.0000
486 APHASIA 1 0.0000
487 LACRIMATION INCREASED 1 0.0000
488 HYPERTENSION 7 0.0000
489 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
490 CORONARY ARTERY DISEASE 1 0.0000
491 THERAPEUTIC RESPONSE DECREASED 2 0.0000
492 SUICIDE ATTEMPT 2 0.0000
493 EPILEPSY 1 0.0000
494 DRUG ADMINISTRATION ERROR 1 0.0000
495 EMOTIONAL DISORDER 1 0.0000
496 CARDIAC DISORDER 3 0.0000
497 SWELLING 3 0.0000
498 NERVOUS SYSTEM DISORDER 1 0.0000
499 PULMONARY EMBOLISM 3 0.0000
500 INTENTIONAL OVERDOSE 2 0.0000
501 HIP FRACTURE 1 0.0000
502 DEEP VEIN THROMBOSIS 2 0.0000
503 AMNESIA 2 0.0000
504 BLOOD CREATININE INCREASED 2 0.0000
505 PAIN IN EXTREMITY 9 0.0000
506 CHOLELITHIASIS 1 0.0000
507 IMPAIRED HEALING 1 0.0000
508 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
509 EXPIRED PRODUCT ADMINISTERED 1 0.0000
510 VIRAL INFECTION 1 0.0000
511 FALL 10 0.0000
512 FUNGAL INFECTION 1 0.0000
513 NEOPLASM MALIGNANT 2 0.0000
514 SOMNOLENCE 6 0.0000
515 EYE PRURITUS 1 0.0000
516 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
517 CONDITION AGGRAVATED 9 0.0000
518 ANGER 1 0.0000
519 URINARY TRACT INFECTION 5 0.0000
520 MULTIPLE SCLEROSIS RELAPSE 2 0.0000
521 GASTRIC DISORDER 1 0.0000
522 ILLNESS 3 0.0000
523 NAUSEA 23 0.0000
524 NIGHTMARE 1 0.0000
525 ABDOMINAL DISTENSION 3 0.0000
526 HYPERKALAEMIA 1 0.0000
527 COVID-19 5 0.0000
528 HEART RATE DECREASED 1 0.0000
529 LYMPHADENOPATHY 1 0.0000
530 PAIN 17 0.0000
531 DRUG EFFECT INCOMPLETE 1 0.0000
532 WRONG TECHNIQUE IN DRUG USAGE PROCESS 1 0.0000
533 C-REACTIVE PROTEIN INCREASED 1 0.0000
534 MALAISE 12 0.0000
535 AGITATION 2 0.0000
536 PRODUCT DOSE OMISSION ISSUE 8 0.0000
537 DYSGEUSIA 2 0.0000
538 SEPSIS 3 0.0000
539 WEIGHT INCREASED 6 0.0000
540 HYPOAESTHESIA 4 0.0000
541 DYSARTHRIA 1 0.0000
542 HALLUCINATION 2 0.0000
543 ARTHRALGIA 11 0.0000
544 BLOOD PRESSURE INCREASED 4 0.0000
545 GAIT DISTURBANCE 5 0.0000
546 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
547 CHILLS 3 0.0000
548 ARTHRITIS 2 0.0000
549 ABORTION SPONTANEOUS 1 0.0000
550 CARDIAC FAILURE CONGESTIVE 2 0.0000
551 THROMBOSIS 2 0.0000
552 EXTRA DOSE ADMINISTERED 1 0.0000
553 POLLAKIURIA 1 0.0000
554 URTICARIA 4 0.0000
555 OSTEOARTHRITIS 1 0.0000
556 HYPOACUSIS 1 0.0000
557 MENTAL DISORDER 1 0.0000
558 DYSPNOEA 13 0.0000
559 CONSTIPATION 5 0.0000
560 PRODUCT STORAGE ERROR 2 0.0000
561 DRUG WITHDRAWAL SYNDROME 2 0.0000
562 DRY SKIN 3 0.0000
563 PULMONARY OEDEMA 1 0.0000
564 SKIN IRRITATION 1 0.0000
565 NASOPHARYNGITIS 4 0.0000
566 PNEUMONIA 7 0.0000
567 CHEST PAIN 4 0.0000
568 ABDOMINAL PAIN 5 0.0000
569 OCULAR HYPERAEMIA 1 0.0000
570 DYSPHAGIA 2 0.0000
571 ANAEMIA 4 0.0000
572 MIGRAINE 2 0.0000
573 PRODUCTIVE COUGH 1 0.0000
574 MULTIPLE SCLEROSIS 1 0.0000
575 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
576 DRUG INTOLERANCE 2 0.0000
577 DYSPEPSIA 2 0.0000
578 PYREXIA 7 0.0000
579 DIARRHOEA 13 0.0000
580 SYNCOPE 2 0.0000
581 CELLULITIS 1 0.0000
582 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 4 0.0000
583 THERAPY CESSATION 1 0.0000
584 HAEMOGLOBIN DECREASED 2 0.0000
585 ABDOMINAL PAIN UPPER 4 0.0000
586 VOMITING 9 0.0000
587 ECZEMA 1 0.0000
588 MUSCULOSKELETAL PAIN 1 0.0000
589 PANCREATITIS 1 0.0000
590 DRUG INTERACTION 3 0.0000
591 PLATELET COUNT DECREASED 2 0.0000
592 CONFUSIONAL STATE 3 0.0000
593 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
594 TREATMENT NONCOMPLIANCE 1 0.0000
595 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
596 MEDICATION ERROR 1 0.0000
597 ABDOMINAL DISCOMFORT 3 0.0000
598 THROMBOCYTOPENIA 2 0.0000
599 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
600 BACK PAIN 4 0.0000
601 OFF LABEL USE 15 0.0000
602 DYSPHONIA 1 0.0000
603 WHEEZING 1 0.0000
604 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3 0.0000
605 STOMATITIS 1 0.0000
606 FEELING HOT 1 0.0000
607 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
608 PRODUCT USE IN UNAPPROVED INDICATION 4 0.0000
609 PRODUCT USE ISSUE 3 0.0000
610 RHINORRHOEA 1 0.0000
611 PRODUCT DOSE OMISSION 1 0.0000
612 ALOPECIA 3 0.0000
613 FEBRILE NEUTROPENIA 1 0.0000
614 RENAL FAILURE 2 0.0000
615 BLOOD PRESSURE DECREASED 1 0.0000
616 DEHYDRATION 2 0.0000
617 INJECTION SITE PRURITUS 1 0.0000
618 HEPATIC ENZYME INCREASED 1 0.0000
619 ERYTHEMA 3 0.0000
620 MEMORY IMPAIRMENT 2 0.0000
621 INJECTION SITE REACTION 1 0.0000
622 BURNING SENSATION 1 0.0000
623 DEVICE MALFUNCTION 1 0.0000
624 INJURY 1 0.0000
625 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
626 THERAPY INTERRUPTED 1 0.0000
627 SKIN BURNING SENSATION 1 0.0000
628 MOBILITY DECREASED 1 0.0000
629 HOT FLUSH 1 0.0000
630 INJECTION SITE SWELLING 1 0.0000
631 INJECTION SITE BRUISING 1 0.0000
632 CARDIAC FAILURE 1 0.0000
633 DRUG INEFFECTIVE 16 0.0000
634 DRUG DOSE OMISSION 2 0.0000
635 RENAL IMPAIRMENT 1 0.0000
636 TOXICITY TO VARIOUS AGENTS 2 0.0000
637 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
638 ADVERSE DRUG REACTION 1 0.0000
639 ADVERSE EVENT 1 0.0000
640 HYPERSENSITIVITY 2 0.0000
641 BLOOD GLUCOSE INCREASED 2 0.0000
642 CONTUSION 1 0.0000
643 HEART RATE INCREASED 1 0.0000
644 HYPOTENSION 2 0.0000
645 FLUSHING 1 0.0000
646 INJECTION SITE PAIN 3 0.0000
647 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
648 RHEUMATOID ARTHRITIS 1 0.0000
649 INCORRECT DOSE ADMINISTERED 2 0.0000
650 SEIZURE 1 0.0000
651 PRURITUS 3 0.0000
652 PSORIASIS 1 0.0000
653 PRODUCT QUALITY ISSUE 1 0.0000
654 NEUTROPENIA 1 0.0000
655 VISION BLURRED 1 0.0000
656 INFECTION 1 0.0000
657 RASH 3 0.0000
658 DRUG DEPENDENCE 1 0.0000
659 CEREBROVASCULAR ACCIDENT 1 0.0000
660 MYOCARDIAL INFARCTION 1 0.0000
661 NO ADVERSE EVENT 1 0.0000
662 OVERDOSE 1 0.0000
663 DEATH 2 0.0000